nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Ceruletide—CCKAR—obesity	0.0178	0.851	CrCbGaD
Nafarelin—GNRHR—hindbrain—obesity	0.0139	0.576	CbGeAlD
Nafarelin—GNRHR—pituitary gland—obesity	0.00574	0.239	CbGeAlD
Nafarelin—GNRHR—endocrine gland—obesity	0.00445	0.185	CbGeAlD
Nafarelin—Pentagastrin—BCHE—obesity	0.00253	0.121	CrCbGaD
Nafarelin—Myalgia—Diethylpropion—obesity	0.00186	0.00313	CcSEcCtD
Nafarelin—Chest pain—Diethylpropion—obesity	0.00186	0.00313	CcSEcCtD
Nafarelin—Insomnia—Phentermine—obesity	0.00185	0.00312	CcSEcCtD
Nafarelin—Hepatic function abnormal—Bupropion—obesity	0.00184	0.0031	CcSEcCtD
Nafarelin—Constipation—Phenylpropanolamine—obesity	0.00183	0.00309	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Sibutramine—obesity	0.00183	0.00308	CcSEcCtD
Nafarelin—Dizziness—Benzphetamine—obesity	0.00182	0.00306	CcSEcCtD
Nafarelin—Affect lability—Sibutramine—obesity	0.00182	0.00306	CcSEcCtD
Nafarelin—Headache—Methamphetamine—obesity	0.00179	0.00301	CcSEcCtD
Nafarelin—Eye pain—Bupropion—obesity	0.00178	0.003	CcSEcCtD
Nafarelin—Myalgia—Cimetidine—obesity	0.00177	0.00298	CcSEcCtD
Nafarelin—Arthralgia—Cimetidine—obesity	0.00177	0.00298	CcSEcCtD
Nafarelin—Constipation—Phentermine—obesity	0.00175	0.00295	CcSEcCtD
Nafarelin—Mood swings—Sibutramine—obesity	0.00175	0.00294	CcSEcCtD
Nafarelin—Dry skin—Orlistat—obesity	0.00175	0.00294	CcSEcCtD
Nafarelin—Libido decreased—Bupropion—obesity	0.00173	0.00292	CcSEcCtD
Nafarelin—Hyperhidrosis—Diethylpropion—obesity	0.00172	0.0029	CcSEcCtD
Nafarelin—Headache—Benzphetamine—obesity	0.00172	0.0029	CcSEcCtD
Nafarelin—Hot flush—Bupropion—obesity	0.00172	0.0029	CcSEcCtD
Nafarelin—Diarrhoea—Phendimetrazine—obesity	0.00172	0.00289	CcSEcCtD
Nafarelin—Increased appetite—Bupropion—obesity	0.00171	0.00288	CcSEcCtD
Nafarelin—Menopausal symptoms—Bupropion—obesity	0.0017	0.00287	CcSEcCtD
Nafarelin—Dry skin—Sibutramine—obesity	0.00169	0.00285	CcSEcCtD
Nafarelin—Gastritis—Orlistat—obesity	0.00169	0.00284	CcSEcCtD
Nafarelin—Acne—Topiramate—obesity	0.00168	0.00283	CcSEcCtD
Nafarelin—Abdominal distension—Orlistat—obesity	0.00166	0.00279	CcSEcCtD
Nafarelin—Dizziness—Phendimetrazine—obesity	0.00166	0.00279	CcSEcCtD
Nafarelin—Cerebrovascular accident—Bupropion—obesity	0.00164	0.00276	CcSEcCtD
Nafarelin—Nausea—Benzphetamine—obesity	0.00163	0.00275	CcSEcCtD
Nafarelin—Gastritis—Sibutramine—obesity	0.00163	0.00275	CcSEcCtD
Nafarelin—Urticaria—Phentermine—obesity	0.00163	0.00274	CcSEcCtD
Nafarelin—Muscular weakness—Sibutramine—obesity	0.00163	0.00274	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Diethylpropion—obesity	0.00163	0.00274	CcSEcCtD
Nafarelin—Breast pain—Topiramate—obesity	0.00162	0.00272	CcSEcCtD
Nafarelin—Insomnia—Diethylpropion—obesity	0.00161	0.00272	CcSEcCtD
Nafarelin—Abdominal distension—Sibutramine—obesity	0.00161	0.0027	CcSEcCtD
Nafarelin—Sweating increased—Orlistat—obesity	0.00161	0.0027	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Bupropion—obesity	0.0016	0.00269	CcSEcCtD
Nafarelin—Dyspnoea—Diethylpropion—obesity	0.00159	0.00268	CcSEcCtD
Nafarelin—Affect lability—Bupropion—obesity	0.00158	0.00267	CcSEcCtD
Nafarelin—Headache—Phendimetrazine—obesity	0.00157	0.00265	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Cimetidine—obesity	0.00155	0.0026	CcSEcCtD
Nafarelin—Oliguria—Topiramate—obesity	0.00153	0.00258	CcSEcCtD
Nafarelin—Constipation—Diethylpropion—obesity	0.00153	0.00257	CcSEcCtD
Nafarelin—Mood swings—Bupropion—obesity	0.00152	0.00257	CcSEcCtD
Nafarelin—Dysuria—Sibutramine—obesity	0.00149	0.00251	CcSEcCtD
Nafarelin—Nausea—Phendimetrazine—obesity	0.00149	0.00251	CcSEcCtD
Nafarelin—Dry skin—Bupropion—obesity	0.00147	0.00248	CcSEcCtD
Nafarelin—Asthenia—Phentermine—obesity	0.00147	0.00248	CcSEcCtD
Nafarelin—Depression—Orlistat—obesity	0.00147	0.00247	CcSEcCtD
Nafarelin—Constipation—Cimetidine—obesity	0.00145	0.00244	CcSEcCtD
Nafarelin—Weight increased—Sibutramine—obesity	0.00145	0.00244	CcSEcCtD
Nafarelin—Coordination abnormal—Topiramate—obesity	0.00144	0.00242	CcSEcCtD
Nafarelin—Gastritis—Bupropion—obesity	0.00142	0.0024	CcSEcCtD
Nafarelin—Muscular weakness—Bupropion—obesity	0.00142	0.00239	CcSEcCtD
Nafarelin—Depression—Sibutramine—obesity	0.00142	0.00239	CcSEcCtD
Nafarelin—Urticaria—Diethylpropion—obesity	0.00142	0.00239	CcSEcCtD
Nafarelin—Dizziness—Phenylpropanolamine—obesity	0.00142	0.00239	CcSEcCtD
Nafarelin—Pulmonary embolism—Topiramate—obesity	0.00141	0.00238	CcSEcCtD
Nafarelin—Diarrhoea—Phentermine—obesity	0.0014	0.00236	CcSEcCtD
Nafarelin—Acute coronary syndrome—Sibutramine—obesity	0.0014	0.00236	CcSEcCtD
Nafarelin—Abdominal distension—Bupropion—obesity	0.0014	0.00236	CcSEcCtD
Nafarelin—Myocardial infarction—Sibutramine—obesity	0.00139	0.00235	CcSEcCtD
Nafarelin—Conjunctivitis—Sibutramine—obesity	0.00138	0.00233	CcSEcCtD
Nafarelin—Cystitis noninfective—Topiramate—obesity	0.00138	0.00232	CcSEcCtD
Nafarelin—Sinusitis—Orlistat—obesity	0.00138	0.00232	CcSEcCtD
Nafarelin—Urinary incontinence—Topiramate—obesity	0.00136	0.0023	CcSEcCtD
Nafarelin—Cystitis—Topiramate—obesity	0.00136	0.0023	CcSEcCtD
Nafarelin—Vomiting—Phenylpropanolamine—obesity	0.00136	0.00229	CcSEcCtD
Nafarelin—Dizziness—Phentermine—obesity	0.00136	0.00228	CcSEcCtD
Nafarelin—Sweating increased—Bupropion—obesity	0.00135	0.00228	CcSEcCtD
Nafarelin—Rash—Phenylpropanolamine—obesity	0.00135	0.00227	CcSEcCtD
Nafarelin—Dermatitis—Phenylpropanolamine—obesity	0.00135	0.00227	CcSEcCtD
Nafarelin—Epistaxis—Sibutramine—obesity	0.00134	0.00226	CcSEcCtD
Nafarelin—Sinusitis—Sibutramine—obesity	0.00133	0.00225	CcSEcCtD
Nafarelin—Vomiting—Phentermine—obesity	0.0013	0.0022	CcSEcCtD
Nafarelin—Dysuria—Bupropion—obesity	0.0013	0.00219	CcSEcCtD
Nafarelin—Rash—Phentermine—obesity	0.00129	0.00218	CcSEcCtD
Nafarelin—Dermatitis—Phentermine—obesity	0.00129	0.00217	CcSEcCtD
Nafarelin—Headache—Phentermine—obesity	0.00128	0.00216	CcSEcCtD
Nafarelin—Rash maculo-papular—Topiramate—obesity	0.00128	0.00216	CcSEcCtD
Nafarelin—Rhinitis—Sibutramine—obesity	0.00128	0.00215	CcSEcCtD
Nafarelin—Neoplasm—Topiramate—obesity	0.00128	0.00215	CcSEcCtD
Nafarelin—Bladder pain—Topiramate—obesity	0.00128	0.00215	CcSEcCtD
Nafarelin—Nausea—Phenylpropanolamine—obesity	0.00127	0.00214	CcSEcCtD
Nafarelin—Weight increased—Bupropion—obesity	0.00127	0.00213	CcSEcCtD
Nafarelin—Weight decreased—Bupropion—obesity	0.00126	0.00212	CcSEcCtD
Nafarelin—Acute coronary syndrome—Bupropion—obesity	0.00122	0.00206	CcSEcCtD
Nafarelin—Diarrhoea—Diethylpropion—obesity	0.00122	0.00206	CcSEcCtD
Nafarelin—Nausea—Phentermine—obesity	0.00122	0.00205	CcSEcCtD
Nafarelin—Asthenia—Cimetidine—obesity	0.00122	0.00205	CcSEcCtD
Nafarelin—Myocardial infarction—Bupropion—obesity	0.00122	0.00205	CcSEcCtD
Nafarelin—Conjunctivitis—Bupropion—obesity	0.00121	0.00203	CcSEcCtD
Nafarelin—Ear pain—Topiramate—obesity	0.0012	0.00202	CcSEcCtD
Nafarelin—Dizziness—Diethylpropion—obesity	0.00118	0.00199	CcSEcCtD
Nafarelin—Epistaxis—Bupropion—obesity	0.00117	0.00197	CcSEcCtD
Nafarelin—Alopecia—Orlistat—obesity	0.00117	0.00196	CcSEcCtD
Nafarelin—Sinusitis—Bupropion—obesity	0.00116	0.00196	CcSEcCtD
Nafarelin—Diarrhoea—Cimetidine—obesity	0.00116	0.00196	CcSEcCtD
Nafarelin—Mental disorder—Orlistat—obesity	0.00116	0.00195	CcSEcCtD
Nafarelin—Malnutrition—Orlistat—obesity	0.00115	0.00193	CcSEcCtD
Nafarelin—Eye pain—Topiramate—obesity	0.00114	0.00191	CcSEcCtD
Nafarelin—Vomiting—Diethylpropion—obesity	0.00113	0.00191	CcSEcCtD
Nafarelin—Alopecia—Sibutramine—obesity	0.00113	0.0019	CcSEcCtD
Nafarelin—Rash—Diethylpropion—obesity	0.00112	0.00189	CcSEcCtD
Nafarelin—Dysgeusia—Orlistat—obesity	0.00112	0.00189	CcSEcCtD
Nafarelin—Dermatitis—Diethylpropion—obesity	0.00112	0.00189	CcSEcCtD
Nafarelin—Dizziness—Cimetidine—obesity	0.00112	0.00189	CcSEcCtD
Nafarelin—Headache—Diethylpropion—obesity	0.00112	0.00188	CcSEcCtD
Nafarelin—Rhinitis—Bupropion—obesity	0.00112	0.00188	CcSEcCtD
Nafarelin—Malnutrition—Sibutramine—obesity	0.00111	0.00187	CcSEcCtD
Nafarelin—Libido decreased—Topiramate—obesity	0.00111	0.00186	CcSEcCtD
Nafarelin—Hot flush—Topiramate—obesity	0.0011	0.00184	CcSEcCtD
Nafarelin—Increased appetite—Topiramate—obesity	0.00109	0.00184	CcSEcCtD
Nafarelin—Tension—Sibutramine—obesity	0.00109	0.00184	CcSEcCtD
Nafarelin—Dysgeusia—Sibutramine—obesity	0.00109	0.00183	CcSEcCtD
Nafarelin—Menopausal symptoms—Topiramate—obesity	0.00109	0.00183	CcSEcCtD
Nafarelin—Nervousness—Sibutramine—obesity	0.00108	0.00182	CcSEcCtD
Nafarelin—Vomiting—Cimetidine—obesity	0.00108	0.00182	CcSEcCtD
Nafarelin—Rash—Cimetidine—obesity	0.00107	0.0018	CcSEcCtD
Nafarelin—Dermatitis—Cimetidine—obesity	0.00107	0.0018	CcSEcCtD
Nafarelin—Headache—Cimetidine—obesity	0.00106	0.00179	CcSEcCtD
Nafarelin—Nausea—Diethylpropion—obesity	0.00106	0.00178	CcSEcCtD
Nafarelin—Vertigo—Orlistat—obesity	0.00103	0.00174	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Topiramate—obesity	0.00102	0.00171	CcSEcCtD
Nafarelin—Palpitations—Orlistat—obesity	0.00101	0.00171	CcSEcCtD
Nafarelin—Affect lability—Topiramate—obesity	0.00101	0.0017	CcSEcCtD
Nafarelin—Nausea—Cimetidine—obesity	0.00101	0.0017	CcSEcCtD
Nafarelin—Vertigo—Sibutramine—obesity	0.000998	0.00168	CcSEcCtD
Nafarelin—Convulsion—Orlistat—obesity	0.000995	0.00168	CcSEcCtD
Nafarelin—Alopecia—Bupropion—obesity	0.000983	0.00166	CcSEcCtD
Nafarelin—Palpitations—Sibutramine—obesity	0.000982	0.00165	CcSEcCtD
Nafarelin—Myalgia—Orlistat—obesity	0.000978	0.00165	CcSEcCtD
Nafarelin—Chest pain—Orlistat—obesity	0.000978	0.00165	CcSEcCtD
Nafarelin—Mental disorder—Bupropion—obesity	0.000975	0.00164	CcSEcCtD
Nafarelin—Mood swings—Topiramate—obesity	0.000971	0.00163	CcSEcCtD
Nafarelin—Malnutrition—Bupropion—obesity	0.000969	0.00163	CcSEcCtD
Nafarelin—Convulsion—Sibutramine—obesity	0.000963	0.00162	CcSEcCtD
Nafarelin—Tension—Bupropion—obesity	0.000951	0.0016	CcSEcCtD
Nafarelin—Dysgeusia—Bupropion—obesity	0.000949	0.0016	CcSEcCtD
Nafarelin—Arthralgia—Sibutramine—obesity	0.000946	0.00159	CcSEcCtD
Nafarelin—Myalgia—Sibutramine—obesity	0.000946	0.00159	CcSEcCtD
Nafarelin—Chest pain—Sibutramine—obesity	0.000946	0.00159	CcSEcCtD
Nafarelin—Nervousness—Bupropion—obesity	0.000941	0.00158	CcSEcCtD
Nafarelin—Oedema—Orlistat—obesity	0.000937	0.00158	CcSEcCtD
Nafarelin—Gastritis—Topiramate—obesity	0.000907	0.00153	CcSEcCtD
Nafarelin—Oedema—Sibutramine—obesity	0.000907	0.00153	CcSEcCtD
Nafarelin—Hyperhidrosis—Orlistat—obesity	0.000906	0.00153	CcSEcCtD
Nafarelin—Muscular weakness—Topiramate—obesity	0.000904	0.00152	CcSEcCtD
Nafarelin—Shock—Sibutramine—obesity	0.000892	0.0015	CcSEcCtD
Nafarelin—Abdominal distension—Topiramate—obesity	0.000892	0.0015	CcSEcCtD
Nafarelin—Hyperhidrosis—Sibutramine—obesity	0.000877	0.00148	CcSEcCtD
Nafarelin—Vertigo—Bupropion—obesity	0.00087	0.00147	CcSEcCtD
Nafarelin—Anorexia—Sibutramine—obesity	0.000865	0.00146	CcSEcCtD
Nafarelin—Sweating increased—Topiramate—obesity	0.000863	0.00145	CcSEcCtD
Nafarelin—Palpitations—Bupropion—obesity	0.000856	0.00144	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Orlistat—obesity	0.000854	0.00144	CcSEcCtD
Nafarelin—Insomnia—Orlistat—obesity	0.000848	0.00143	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—HCRT—obesity	0.000843	0.00233	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PMCH—obesity	0.000843	0.00233	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPY5R—obesity	0.000843	0.00233	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NMU—obesity	0.000843	0.00233	CbGpPWpGaD
Nafarelin—Paraesthesia—Orlistat—obesity	0.000842	0.00142	CcSEcCtD
Nafarelin—Convulsion—Bupropion—obesity	0.000839	0.00141	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—obesity	0.000831	0.0023	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	0.00083	0.0023	CbGpPWpGaD
Nafarelin—Dysuria—Topiramate—obesity	0.000828	0.00139	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Sibutramine—obesity	0.000826	0.00139	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—MKS1—obesity	0.000825	0.00228	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—KIF7—obesity	0.000825	0.00228	CbGpPWpGaD
Nafarelin—Myalgia—Bupropion—obesity	0.000825	0.00139	CcSEcCtD
Nafarelin—Chest pain—Bupropion—obesity	0.000825	0.00139	CcSEcCtD
Nafarelin—Arthralgia—Bupropion—obesity	0.000825	0.00139	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—NPS—obesity	0.000821	0.00227	CbGpPWpGaD
Nafarelin—Insomnia—Sibutramine—obesity	0.00082	0.00138	CcSEcCtD
Nafarelin—Decreased appetite—Orlistat—obesity	0.000815	0.00137	CcSEcCtD
Nafarelin—Paraesthesia—Sibutramine—obesity	0.000814	0.00137	CcSEcCtD
Nafarelin—Dyspnoea—Sibutramine—obesity	0.000809	0.00136	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—MC4R—obesity	0.000808	0.00224	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—MC3R—obesity	0.000808	0.00224	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPY2R—obesity	0.000808	0.00224	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPY1R—obesity	0.000808	0.00224	CbGpPWpGaD
Nafarelin—Weight increased—Topiramate—obesity	0.000806	0.00136	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—HTR2C—obesity	0.000805	0.00223	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—DRD1—obesity	0.000805	0.00223	CbGpPWpGaD
Nafarelin—Weight decreased—Topiramate—obesity	0.000801	0.00135	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—PPY—obesity	0.000792	0.00219	CbGpPWpGaD
Nafarelin—Oedema—Bupropion—obesity	0.000791	0.00133	CcSEcCtD
Nafarelin—Decreased appetite—Sibutramine—obesity	0.000788	0.00133	CcSEcCtD
Nafarelin—Depression—Topiramate—obesity	0.000788	0.00133	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—ADRB1—obesity	0.00078	0.00216	CbGpPWpGaD
Nafarelin—Shock—Bupropion—obesity	0.000778	0.00131	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—PRKCH—obesity	0.000778	0.00215	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GIP—obesity	0.000778	0.00215	CbGpPWpGaD
Nafarelin—Constipation—Sibutramine—obesity	0.000776	0.00131	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—obesity	0.000768	0.00213	CbGpPWpGaD
Nafarelin—Conjunctivitis—Topiramate—obesity	0.000768	0.00129	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—NMU—obesity	0.000765	0.00212	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPY5R—obesity	0.000765	0.00212	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PMCH—obesity	0.000765	0.00212	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HCRT—obesity	0.000765	0.00212	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Bupropion—obesity	0.000764	0.00129	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—GHRL—obesity	0.000763	0.00211	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—DRD4—obesity	0.000757	0.0021	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRLH—obesity	0.000754	0.00209	CbGpPWpGaD
Nafarelin—Anorexia—Bupropion—obesity	0.000754	0.00127	CcSEcCtD
Nafarelin—Epistaxis—Topiramate—obesity	0.000745	0.00125	CcSEcCtD
Nafarelin—Urticaria—Orlistat—obesity	0.000745	0.00125	CcSEcCtD
Nafarelin—Sinusitis—Topiramate—obesity	0.000741	0.00125	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	0.000736	0.00204	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—MC3R—obesity	0.000734	0.00203	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—MC4R—obesity	0.000734	0.00203	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPY2R—obesity	0.000734	0.00203	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPY1R—obesity	0.000734	0.00203	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CNR1—obesity	0.000723	0.002	CbGpPWpGaD
Nafarelin—Urticaria—Sibutramine—obesity	0.000721	0.00121	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Bupropion—obesity	0.00072	0.00121	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—PPY—obesity	0.000719	0.00199	CbGpPWpGaD
Nafarelin—Insomnia—Bupropion—obesity	0.000715	0.0012	CcSEcCtD
Nafarelin—Rhinitis—Topiramate—obesity	0.000711	0.0012	CcSEcCtD
Nafarelin—Paraesthesia—Bupropion—obesity	0.00071	0.0012	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—GIP—obesity	0.000706	0.00196	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PRKCH—obesity	0.000706	0.00196	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—DRD2—obesity	0.000705	0.00195	CbGpPWpGaD
Nafarelin—Dyspnoea—Bupropion—obesity	0.000705	0.00119	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—GCG—obesity	0.000698	0.00193	CbGpPWpGaD
Nafarelin—Decreased appetite—Bupropion—obesity	0.000687	0.00116	CcSEcCtD
Nafarelin—GNRHR—G alpha (q) signalling events—PIK3R1—obesity	0.000682	0.00189	CbGpPWpGaD
Nafarelin—Constipation—Bupropion—obesity	0.000676	0.00114	CcSEcCtD
Nafarelin—Asthenia—Orlistat—obesity	0.000672	0.00113	CcSEcCtD
Nafarelin—Pruritus—Orlistat—obesity	0.000663	0.00112	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—ADRB3—obesity	0.000661	0.00183	CbGpPWpGaD
Nafarelin—Asthenia—Sibutramine—obesity	0.000651	0.0011	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	0.000649	0.0018	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—obesity	0.000648	0.00179	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GAL—obesity	0.000646	0.00179	CbGpPWpGaD
Nafarelin—Pruritus—Sibutramine—obesity	0.000642	0.00108	CcSEcCtD
Nafarelin—Diarrhoea—Orlistat—obesity	0.000641	0.00108	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—C5AR1—obesity	0.000639	0.00177	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—ADRB2—obesity	0.000632	0.00175	CbGpPWpGaD
Nafarelin—Urticaria—Bupropion—obesity	0.000628	0.00106	CcSEcCtD
Nafarelin—Alopecia—Topiramate—obesity	0.000627	0.00105	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—GHRH—obesity	0.000625	0.00173	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NMB—obesity	0.000625	0.00173	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—obesity	0.000621	0.00172	CbGpPWpGaD
Nafarelin—Mental disorder—Topiramate—obesity	0.000621	0.00105	CcSEcCtD
Nafarelin—Diarrhoea—Sibutramine—obesity	0.000621	0.00104	CcSEcCtD
Nafarelin—Dizziness—Orlistat—obesity	0.00062	0.00104	CcSEcCtD
Nafarelin—Malnutrition—Topiramate—obesity	0.000617	0.00104	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	0.000615	0.0017	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—obesity	0.00061	0.00169	CbGpPWpGaD
Nafarelin—Tension—Topiramate—obesity	0.000606	0.00102	CcSEcCtD
Nafarelin—Dysgeusia—Topiramate—obesity	0.000604	0.00102	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—GNB3—obesity	0.000602	0.00167	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADRB3—obesity	0.0006	0.00166	CbGpPWpGaD
Nafarelin—Dizziness—Sibutramine—obesity	0.0006	0.00101	CcSEcCtD
Nafarelin—Nervousness—Topiramate—obesity	0.000599	0.00101	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—FFAR4—obesity	0.000596	0.00165	CbGpPWpGaD
Nafarelin—Vomiting—Orlistat—obesity	0.000596	0.001	CcSEcCtD
Nafarelin—Rash—Orlistat—obesity	0.000591	0.000995	CcSEcCtD
Nafarelin—Dermatitis—Orlistat—obesity	0.00059	0.000994	CcSEcCtD
Nafarelin—Desmopressin—PTGS2—obesity	0.00059	0.0282	CrCbGaD
Nafarelin—Headache—Orlistat—obesity	0.000587	0.000988	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—GAL—obesity	0.000586	0.00162	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GNAS—obesity	0.000586	0.00162	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCK—obesity	0.000584	0.00162	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—C5AR1—obesity	0.00058	0.00161	CbGpPWpGaD
Nafarelin—Vomiting—Sibutramine—obesity	0.000577	0.000971	CcSEcCtD
Nafarelin—Rash—Sibutramine—obesity	0.000572	0.000963	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—MCHR1—obesity	0.000572	0.00158	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GHSR—obesity	0.000572	0.00158	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—BRS3—obesity	0.000572	0.00158	CbGpPWpGaD
Nafarelin—Dermatitis—Sibutramine—obesity	0.000571	0.000962	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—GLP1R—obesity	0.000569	0.00158	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—obesity	0.000569	0.00157	CbGpPWpGaD
Nafarelin—Headache—Sibutramine—obesity	0.000568	0.000957	CcSEcCtD
Nafarelin—Asthenia—Bupropion—obesity	0.000567	0.000955	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CCL5—obesity	0.00056	0.00155	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HRH3—obesity	0.00056	0.00155	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCKAR—obesity	0.00056	0.00155	CbGpPWpGaD
Nafarelin—Pruritus—Bupropion—obesity	0.000559	0.000942	CcSEcCtD
Nafarelin—Nausea—Orlistat—obesity	0.000557	0.000937	CcSEcCtD
Nafarelin—Vertigo—Topiramate—obesity	0.000555	0.000934	CcSEcCtD
Nafarelin—Palpitations—Topiramate—obesity	0.000545	0.000918	CcSEcCtD
Nafarelin—Diarrhoea—Bupropion—obesity	0.000541	0.000911	CcSEcCtD
Nafarelin—Nausea—Sibutramine—obesity	0.000539	0.000907	CcSEcCtD
Nafarelin—Convulsion—Topiramate—obesity	0.000535	0.0009	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—SH2B1—obesity	0.000532	0.00147	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GH1—obesity	0.000532	0.00147	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRLHR—obesity	0.000532	0.00147	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCK—obesity	0.00053	0.00147	CbGpPWpGaD
Nafarelin—Chest pain—Topiramate—obesity	0.000525	0.000885	CcSEcCtD
Nafarelin—Myalgia—Topiramate—obesity	0.000525	0.000885	CcSEcCtD
Nafarelin—Arthralgia—Topiramate—obesity	0.000525	0.000885	CcSEcCtD
Nafarelin—Dizziness—Bupropion—obesity	0.000523	0.00088	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	0.000518	0.00143	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GLP1R—obesity	0.000517	0.00143	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCKAR—obesity	0.000508	0.00141	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HRH3—obesity	0.000508	0.00141	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPY—obesity	0.000507	0.0014	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	0.000507	0.0014	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IAPP—obesity	0.000504	0.0014	CbGpPWpGaD
Nafarelin—Oedema—Topiramate—obesity	0.000504	0.000848	CcSEcCtD
Nafarelin—Vomiting—Bupropion—obesity	0.000503	0.000846	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PYY—obesity	0.0005	0.00138	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APLN—obesity	0.0005	0.00138	CbGpPWpGaD
Nafarelin—Rash—Bupropion—obesity	0.000499	0.000839	CcSEcCtD
Nafarelin—Dermatitis—Bupropion—obesity	0.000498	0.000839	CcSEcCtD
Nafarelin—Shock—Topiramate—obesity	0.000496	0.000834	CcSEcCtD
Nafarelin—Headache—Bupropion—obesity	0.000495	0.000834	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—HTR2A—obesity	0.000494	0.00137	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—C3—obesity	0.000493	0.00137	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PRKAR2B—obesity	0.000489	0.00136	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HTR1B—obesity	0.000489	0.00136	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CRH—obesity	0.000489	0.00136	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Topiramate—obesity	0.000487	0.00082	CcSEcCtD
Nafarelin—Anorexia—Topiramate—obesity	0.00048	0.000808	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PNLIP—obesity	0.000474	0.00131	CbGpPWpGaD
Nafarelin—Nausea—Bupropion—obesity	0.00047	0.000791	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—AGT—obesity	0.000469	0.0013	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPS—obesity	0.000464	0.00128	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SDC3—obesity	0.000462	0.00128	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPY—obesity	0.000461	0.00128	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Topiramate—obesity	0.000459	0.000773	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—IAPP—obesity	0.000458	0.00127	CbGpPWpGaD
Nafarelin—Insomnia—Topiramate—obesity	0.000456	0.000767	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—HTR2C—obesity	0.000455	0.00126	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—DRD1—obesity	0.000455	0.00126	CbGpPWpGaD
Nafarelin—Paraesthesia—Topiramate—obesity	0.000452	0.000762	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—NMU—obesity	0.000452	0.00125	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HCRT—obesity	0.000452	0.00125	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPY5R—obesity	0.000452	0.00125	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PMCH—obesity	0.000452	0.00125	CbGpPWpGaD
Nafarelin—Dyspnoea—Topiramate—obesity	0.000449	0.000756	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—HTR1B—obesity	0.000444	0.00123	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CRH—obesity	0.000444	0.00123	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADRB1—obesity	0.000441	0.00122	CbGpPWpGaD
Nafarelin—Decreased appetite—Topiramate—obesity	0.000438	0.000737	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—NPY2R—obesity	0.000433	0.0012	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MC4R—obesity	0.000433	0.0012	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MC3R—obesity	0.000433	0.0012	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPY1R—obesity	0.000433	0.0012	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—F2—obesity	0.000433	0.0012	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GHRL—obesity	0.000431	0.00119	CbGpPWpGaD
Nafarelin—Constipation—Topiramate—obesity	0.000431	0.000725	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—DRD4—obesity	0.000428	0.00118	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PPY—obesity	0.000425	0.00118	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPS—obesity	0.000421	0.00117	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HDAC8—obesity	0.000417	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRKCH—obesity	0.000417	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GIP—obesity	0.000417	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—DRD1—obesity	0.000413	0.00114	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HTR2C—obesity	0.000413	0.00114	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CNR1—obesity	0.000408	0.00113	CbGpPWpGaD
Nafarelin—Urticaria—Topiramate—obesity	0.0004	0.000674	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—ADRB1—obesity	0.0004	0.00111	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—DRD2—obesity	0.000399	0.0011	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LEPR—obesity	0.000396	0.0011	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GCG—obesity	0.000394	0.00109	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—POMC—obesity	0.000394	0.00109	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GHRL—obesity	0.000392	0.00108	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—DRD4—obesity	0.000388	0.00108	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL2—obesity	0.000386	0.00107	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—PIK3CA—obesity	0.000384	0.00106	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CNR1—obesity	0.000371	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—DRD2—obesity	0.000362	0.001	CbGpPWpGaD
Nafarelin—Asthenia—Topiramate—obesity	0.000361	0.000609	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—GCG—obesity	0.000358	0.000992	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADRB2—obesity	0.000357	0.000989	CbGpPWpGaD
Nafarelin—Pruritus—Topiramate—obesity	0.000356	0.0006	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ADRB3—obesity	0.000355	0.000982	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GAL—obesity	0.000346	0.000959	CbGpPWpGaD
Nafarelin—Diarrhoea—Topiramate—obesity	0.000345	0.00058	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—obesity	0.000343	0.000951	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—C5AR1—obesity	0.000343	0.000949	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GNB3—obesity	0.00034	0.000942	CbGpPWpGaD
Nafarelin—Dizziness—Topiramate—obesity	0.000333	0.000561	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—GNAS—obesity	0.000331	0.000917	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADRB2—obesity	0.000324	0.000898	CbGpPWpGaD
Nafarelin—Vomiting—Topiramate—obesity	0.00032	0.000539	CcSEcCtD
Nafarelin—Rash—Topiramate—obesity	0.000318	0.000535	CcSEcCtD
Nafarelin—Dermatitis—Topiramate—obesity	0.000317	0.000534	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCL5—obesity	0.000317	0.000877	CbGpPWpGaD
Nafarelin—Headache—Topiramate—obesity	0.000316	0.000531	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PRKG1—obesity	0.000313	0.000868	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCK—obesity	0.000313	0.000868	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GNB3—obesity	0.000309	0.000855	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RBP4—obesity	0.000305	0.000846	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GLP1R—obesity	0.000305	0.000846	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	0.000304	0.000842	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GNAS—obesity	0.000301	0.000833	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCKAR—obesity	0.0003	0.000832	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HRH3—obesity	0.0003	0.000832	CbGpPWpGaD
Nafarelin—Nausea—Topiramate—obesity	0.000299	0.000504	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PRKAR2B—obesity	0.000289	0.000801	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL5—obesity	0.000287	0.000796	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PRKCD—obesity	0.000285	0.00079	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NCF2—obesity	0.000279	0.000773	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HTR2A—obesity	0.000279	0.000773	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—C3—obesity	0.000279	0.000772	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPY—obesity	0.000272	0.000754	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IAPP—obesity	0.00027	0.000749	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOC3—obesity	0.00027	0.000749	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AGT—obesity	0.000265	0.000733	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR1B—obesity	0.000263	0.000727	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CRH—obesity	0.000263	0.000727	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SDC1—obesity	0.00026	0.000719	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PRKCD—obesity	0.000259	0.000717	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AKR1C3—obesity	0.000255	0.000707	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HTR2A—obesity	0.000253	0.000702	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—C3—obesity	0.000253	0.000701	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPS—obesity	0.000249	0.000689	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—F2—obesity	0.000245	0.000678	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PRKCB—obesity	0.000245	0.000678	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR2C—obesity	0.000244	0.000676	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—DRD1—obesity	0.000244	0.000676	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AGT—obesity	0.00024	0.000666	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NTRK2—obesity	0.000237	0.000658	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADRB1—obesity	0.000236	0.000655	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PIK3CG—obesity	0.000234	0.000649	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GHRL—obesity	0.000231	0.000641	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PARP1—obesity	0.000231	0.000641	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—DRD4—obesity	0.000229	0.000636	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—POMC—obesity	0.000223	0.000617	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PRKCB—obesity	0.000222	0.000615	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—F2—obesity	0.000222	0.000615	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CNR1—obesity	0.000219	0.000607	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TCF7L2—obesity	0.000215	0.000596	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AKT2—obesity	0.000214	0.000593	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—DRD2—obesity	0.000214	0.000592	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PIK3CG—obesity	0.000213	0.000589	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PTPN1—obesity	0.000212	0.000586	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GCG—obesity	0.000212	0.000586	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PIK3CD—obesity	0.000206	0.00057	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—POMC—obesity	0.000202	0.000561	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRL—obesity	0.000202	0.000559	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—STK11—obesity	0.000199	0.000551	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL2—obesity	0.000198	0.000548	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PLG—obesity	0.000197	0.000545	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—RHOA—obesity	0.000196	0.000544	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AKT2—obesity	0.000195	0.000539	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PIK3R1—obesity	0.000194	0.000538	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—FOXO3—obesity	0.000192	0.000532	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADRB2—obesity	0.000192	0.00053	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SOCS1—obesity	0.000189	0.000522	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PIK3CD—obesity	0.000187	0.000518	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SOCS3—obesity	0.000186	0.000516	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GNB3—obesity	0.000182	0.000505	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—TYK2—obesity	0.00018	0.000498	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PIK3CB—obesity	0.000179	0.000497	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF2—obesity	0.000179	0.000496	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—RHOA—obesity	0.000178	0.000494	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GNAS—obesity	0.000178	0.000492	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PIK3R1—obesity	0.000177	0.000489	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOB—obesity	0.000174	0.000482	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL5—obesity	0.00017	0.00047	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LPL—obesity	0.000166	0.00046	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—FOXO1—obesity	0.000165	0.000457	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RPS6KB1—obesity	0.000165	0.000456	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PIK3CB—obesity	0.000163	0.000451	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRKCD—obesity	0.000153	0.000424	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR2A—obesity	0.00015	0.000415	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—C3—obesity	0.00015	0.000414	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IRS2—obesity	0.000142	0.000394	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AGT—obesity	0.000142	0.000393	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOE—obesity	0.000139	0.000385	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LEP—obesity	0.000139	0.000385	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CAV1—obesity	0.000138	0.000382	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOA1—obesity	0.000138	0.000381	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ESR1—obesity	0.000133	0.000368	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—F2—obesity	0.000131	0.000364	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRKCB—obesity	0.000131	0.000364	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—BAD—obesity	0.00013	0.000359	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PIK3CG—obesity	0.000126	0.000348	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IRS1—obesity	0.000124	0.000344	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—POMC—obesity	0.00012	0.000331	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—INS—obesity	0.000119	0.000329	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL2—obesity	0.000117	0.000324	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF1—obesity	0.000115	0.000319	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AKT2—obesity	0.000115	0.000318	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PIK3CD—obesity	0.00011	0.000306	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PIK3CA—obesity	0.000109	0.000303	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SERPINE1—obesity	0.000109	0.000302	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TYK2—obesity	0.000106	0.000294	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RHOA—obesity	0.000105	0.000292	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NOS3—obesity	0.000104	0.000289	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PIK3R1—obesity	0.000104	0.000289	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PIK3CA—obesity	9.93e-05	0.000275	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MTOR—obesity	9.63e-05	0.000267	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PIK3CB—obesity	9.63e-05	0.000267	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AKT1—obesity	8.94e-05	0.000247	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6—obesity	8.8e-05	0.000244	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MMP9—obesity	8.37e-05	0.000232	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MAPK8—obesity	8.14e-05	0.000225	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AKT1—obesity	8.11e-05	0.000225	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—STAT3—obesity	7.44e-05	0.000206	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MYC—obesity	6.91e-05	0.000191	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TGFB1—obesity	6.9e-05	0.000191	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PIK3CA—obesity	5.87e-05	0.000163	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6—obesity	5.2e-05	0.000144	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AKT1—obesity	4.79e-05	0.000133	CbGpPWpGaD
